SLDB (Solid Biosciences Inc.) Stock Market Reviews

crown

search

Read and share opinions on SLDB (Solid Biosciences Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

SLDB

Solid Biosciences Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Solid Biosciences to Participate at Upcoming Investor Conferences
Nov 11, 2025
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2025
Solid Biosciences to Present at Upcoming Scientific Meetings
Oct 1, 2025
Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting
Sep 25, 2025
Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Jul 23, 2025
Citi Initiates Coverage on Solid Biosciences Inc. (SLDB) with ‘Buy’ Rating and $14 PT
Jul 9, 2025
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
May 28, 2025

Reviews